# Aliskiren and Valsartan vs Valsartan Alone in Patients With Stage II Systolic Hypertension and Type II Diabetes Mellitus

> **NCT00927394** · PHASE4 · COMPLETED · sponsor: **Novartis** · enrollment: 1143 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Aliskiren
- **DRUG:** Valsartan
- **DRUG:** Placebo for Aliskiren
- **DRUG:** Placebo for Valsartan

## Key facts

- **NCT ID:** NCT00927394
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 1143 (ACTUAL)
- **Last updated:** 2012-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00927394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00927394, "Aliskiren and Valsartan vs Valsartan Alone in Patients With Stage II Systolic Hypertension and Type II Diabetes Mellitus". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00927394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*